| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |